Suppr超能文献

人血浆中酸稳定胰蛋白酶抑制剂(ASTI)的酶联免疫吸附测定法的开发与应用

Development and application of an enzyme-linked immunosorbent assay for acid stable trypsin inhibitor (ASTI) in human plasma.

作者信息

Yoshida E, Sumi H, Maruyama M, Mihara H, Sakai R

机构信息

Department of Physiology, Miyazaki Medical College, Japan.

出版信息

Clin Chim Acta. 1987 Aug 14;167(2):155-64. doi: 10.1016/0009-8981(87)90368-8.

Abstract

An enzyme-linked immunosorbent assay (ELISA) for acid-stable trypsin inhibitor was developed using goat antibodies raised against urinary trypsin inhibitor purified from normal human urine. The assay was highly sensitive and precise, and gave reproducible results in the range of 1-1,000 ng/ml. The specificity and sensitivity of this assay permitted measurement of a low content of acid stable trypsin inhibitor in different tissue extracts and body fluids. Using the new method, the mean level in plasma samples taken from healthy individuals was found to be 54.9 +/- 17.4 (mean +/- SD) micrograms/ml and that of acid-treated plasma was 11.5 +/- 3.0 micrograms/ml (n = 27). The calculated specific activity of acid stable trypsin inhibitor in acid treated plasma was 300 U/mg, while that of highly purified inhibitor is 2,100 U/mg. These results suggest the presence of both acid unstable protein having the same antigenicity as urinary trypsin inhibitor and the inactive form of acid stable trypsin inhibitor.

摘要

利用针对从正常人尿液中纯化的尿胰蛋白酶抑制剂产生的山羊抗体,开发了一种用于酸稳定胰蛋白酶抑制剂的酶联免疫吸附测定(ELISA)方法。该测定法高度灵敏且精确,在1 - 1000 ng/ml范围内可得到可重复的结果。该测定法的特异性和灵敏度使得能够测量不同组织提取物和体液中酸稳定胰蛋白酶抑制剂的低含量。使用这种新方法,发现从健康个体采集的血浆样本中的平均水平为54.9 +/- 17.4(平均值 +/- 标准差)微克/毫升,酸处理血浆的平均水平为11.5 +/- 3.0微克/毫升(n = 27)。酸处理血浆中酸稳定胰蛋白酶抑制剂的计算比活性为300 U/mg,而高度纯化抑制剂的比活性为2100 U/mg。这些结果表明存在与尿胰蛋白酶抑制剂具有相同抗原性的酸不稳定蛋白以及酸稳定胰蛋白酶抑制剂的无活性形式。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验